TaiMed Biologics (4147) — Cash Flow Quality Index

Latest as of March 2026: -2.75x

TaiMed Biologics (4147) has a Cash Flow Quality Index of -2.75x as of March 2026. Operating cash flow of NT$-45.01 Million is below net income of NT$16.35 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore TaiMed Biologics cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-2.75x

Operating CF / Net Income

Operating Cash Flow

NT$-45.01 Million

TWD

Net Income

NT$16.35 Million

TWD

Data as of

Mar 2026

Most recent filing

Annual Cash Flow Quality Index for TaiMed Biologics (None–None)

Year-by-year earnings quality comparison for TaiMed Biologics.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.